Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07749495

Skin Closure in Prosthetic Joint Surgery: Comparative Evaluation of the "Barbed Sutures and Skin Glue" Technique (Cica-Pro)

The choice of skin closure (staples vs. monofilament sutures vs. barbed sutures/adhesive) is critical for wound healing quality in prosthetic surgery (hip and knee). The combination of barbed sutures (e.g., Stratafix) and skin glue (e.g., Dermabond) is promising (superior cosmetic outcome, no suture removal, antimicrobial barrier) but has been poorly evaluated prospectively and comparatively in orthopaedics, which justifies this study. The primary objective is to compare the wound healing success rate at two weeks postoperatively between the patient groups. The primary outcome measure is successful wound healing, defined as the absence of wound complications (wound dehiscence, seroma, hematoma, early postoperative infection) during the first two weeks

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women aged over 18 years
  • Patient who has provided written informed consent in duplicate
  • Patient scheduled for a primary hip or knee prosthesis implantation
  • BMI < 30 kg/m²
  • Non-smoker or smoking cessation for more than 4 weeks
  • Patient able to read and understand French
  • Patient with sufficient cognitive capacity to strictly follow study instructions (completion of the calendar)

Exclusion criteria

  • Patient expresses opposition to participating in the study
  • Patients under 18 years of age
  • Patient scheduled for prosthesis revision surgery
  • History of osteoarticular or soft-tissue infection
  • Diabetes, cardiovascular disease, immunodeficiency, or immunosuppressive treatment
  • Consumption of drugs, tobacco, or alcohol
  • Allergy to nickel (staples) or adhesive
  • History of anxiety disorders (generalized anxiety disorder, panic disorder, specific phobia, agoraphobia, social anxiety, separation anxiety), obsessive compulsive disorder (OCD), or post-traumatic stress disorder (PTSD)
  • Patient unable to read and/or understand French
  • Individuals deprived of liberty by judicial or administrative decision
  • Adults unable to consent or incapable of expressing consent
  • Subjects not affiliated with or not benefiting from a social security scheme
  • Pregnant or breastfeeding women

Treatment and study plan

primary knee replacement

Procedure

For patients who have undergone knee replacement surgery (K), the study compares the success of wound healing in surgical wounds closed with barbed sutures and adhesive (Group K1) to those closed with staples (Group K2).

Primary hip replacement.

Procedure

For patients who have undergone hip replacement surgery (H), the study compares the success of wound healing in surgical wounds closed with barbed sutures and adhesive (Group H1) to those closed with monofilament sutures (Group H2).

Primary outcomes

  1. Rate of Successful Wound Healing at 2 Weeks Postoperatively

    Time frame: 2 weeks postoperatively

    Proportion of patients with successful wound healing, defined as the complete absence of wound complications (dehiscence, seroma, hematoma, or early postoperative surgical site infection) during the first 2 postoperative weeks

Secondary outcomes

  1. Severity Stage of Wound Complications According to DISH Classification

    Time frame: 2 weeks postoperatively

    Categorization and staging of surgical wound complications (Dehiscence, Infection, Seroma, Haematoma) based on the international Delphi consensus DISH classification scale.

  2. Patient-Reported Scar Aesthetic Quality Score

    Time frame: 3 months postoperatively

    Assessment of the scar's aesthetic quality completed by the patient using a numerical rating scale from 0 to 100, where 0 represents the worst possible aesthetic outcome and 100 represents the best possible aesthetic outcome. Higher scores indicate greater aesthetic satisfaction.

  3. Change from Baseline in Patient Anxiety Evaluated by Visual Analog Scale (VAS)

    Time frame: Change from baseline at Week 1 and Week 2 postoperatively

    Patient self-reported anxiety level measured on a 10-cm Visual Analog Scale (VAS) ranging from 0 to 10, where 0 represents "no anxiety" and 10 represents "extreme/worst possible anxiety". Higher scores indicate higher levels of anxiety.

  4. Number of Unplanned Postoperative Wound-Related Medical Consultations

    Time frame: Through 3 months postoperatively

    Total count of unplanned wound-related medical consultations (at outpatient clinics or emergency departments) per patient, as recorded in the patient follow-up logbook.

  5. Direct Surgical Closure Material Cost per Patient

    Time frame: At the time of surgery (Day 0)

    Direct cost (in Euros, EUR) of surgical wound closure materials (including sutures, staples, and skin glue) per patient.

  6. Number of Wound-Related Postoperative Phone Calls

    Time frame: Through 3 months postoperatively

    Total count of wound-related telephone calls made by the patient, as recorded in the patient follow-up logbook.

  7. Postoperative Wound Care and Complication Management Costs per Patient

    Time frame: Through 3 months postoperatively

    Direct medical costs (in Euros, EUR) for postoperative care, including dressing consumables, home nursing visits, and management of early wound complications per patient.

  8. Change from Baseline in Patient Anxiety Evaluated by APAIS-C

    Time frame: Change from baseline at Week 1 and Week 2 postoperatively

    Patient anxiety level evaluated using the modified Amsterdam Preoperative Anxiety and Information Scale (APAIS-C). The anxiety subscale score ranges from 4 (minimum possible score) to 20 (maximum possible score). Higher scores indicate higher levels of anxiety.

Study contacts

Contact information is provided by the study sponsor or research team.

Younes KERROUMI, Clinical Research Physician

CONTACT

[email protected]

+33144643384

Sponsors and collaborators

Lead sponsor

Groupe Hospitalier Diaconesses Croix Saint-Simon

Other

Registry information

Acronym: Cica-Pro

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 6, 2026
Registry last updated
Aug 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.